First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI s...

by Volkmar Müller, Markus Ruhnke, Oliver Hoffmann, Andrea Grafe, Oliver Tomé, Werner Fett, Harald-Robert Bruch, Ann-Katrin Sommer-Joos, Andreas Schneeweiss
Published 2021-12-01